Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,381 results for ""LYMPHOPROLIFERATIVE disorders""

Your Filters

Publication : bone marrow transplantation
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Editorial & Opinion

Impact of antithymocyte globulin usage and risk stratification for posttransplant lymphoproliferative disorders in aplastic anemia patients after allogeneic hematopoietic cell transplantation.

  • Authors : Yamamoto R; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.; Hiramoto N

Subjects: Anemia, Aplastic*/Anemia, Aplastic*/Anemia, Aplastic*/therapy ; Antilymphocyte Serum*/Antilymphocyte Serum*/Antilymphocyte Serum*/therapeutic use ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 May; Vol. 59 (5), pp. 688-691. Date of Electronic Publication: 2024 Feb 10.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor.

  • Authors : Paviglianiti A; Duran i Reynals Hospital, Catalan Institute of Oncology, Barcelona, Spain Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain. .; Department of Medicine, Unit of Endocrinology and Diabetes, Università Campus Bio-Medico di Roma, Rome, Italy. .

Subjects: Transplantation Conditioning*/Transplantation Conditioning*/Transplantation Conditioning*/methods ; Graft vs Host Disease*/Graft vs Host Disease*/Graft vs Host Disease*/prevention & control ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/methods

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 May; Vol. 59 (5), pp. 597-603. Date of Electronic Publication: 2024 Feb 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rituximab for posttransplant lymphoproliferative disorder - therapeutic, preemptive, or prophylactic?

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/prevention & control ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/drug therapy ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/etiology

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jan; Vol. 59 (1), pp. 6-11. Date of Electronic Publication: 2023 Nov 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Prevalence, management, and new treatment modalities of EBV-DNA-emia and EBV-PTLD after allo-HCT: survey of Infectious Diseases Working Party EBMT.

  • Authors : Styczynski J; Department of Pediatric Hematology and Oncology, Collegium Medicum Nicolaus Copernicus University Torun, Bydgoszcz, Poland. .; Tridello G

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/epidemiology ; Communicable Diseases* ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/etiology

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jan; Vol. 59 (1), pp. 59-65. Date of Electronic Publication: 2023 Oct 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy.

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/drug therapy ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/drug therapy

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jan; Vol. 59 (1), pp. 52-58. Date of Electronic Publication: 2023 Oct 21.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Incidence and course of Epstein-Barr virus viremia after allogeneic hematopoietic stem cell transplant for adult-onset systemic chronic active Epstein-Barr virus disease.

  • Authors : Vaswani PPM; Department of Hematology, Hokkaido University, Faculty of Medicine, Graduate School of Medicine, Sapporo, Japan.; Section of Hematology, Division of Internal Medicine, National Kidney and Transplant Institute, Quezon City, Philippines.

Subjects: Epstein-Barr Virus Infections* ; Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/complications

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Dec; Vol. 58 (12), pp. 1397-1399. Date of Electronic Publication: 2023 Sep 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Autologous stem cell transplantation for post-transplant lymphoproliferative disorders after solid organ transplantation: a retrospective analysis from the Lymphoma Working Party of the EBMT.

  • Authors : Eyre TA; Department of Haematology, Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. .; Caillard S

Subjects: Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/Hematopoietic Stem Cell Transplantation*/adverse effects ; Lymphoma, Large B-Cell, Diffuse* ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/etiology

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2021 Sep; Vol. 56 (9), pp. 2118-2124. Date of Electronic Publication: 2021 Apr 16.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

CD19 CAR-T therapy in solid organ transplant recipients: case report and systematic review.

  • Authors : Portuguese AJ; University of Washington, Seattle, WA, USA. .; Fred Hutchinson Cancer Center, Seattle, WA, USA. .

Subjects: Epstein-Barr Virus Infections* ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/pathology

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2023 Apr; Vol. 58 (4), pp. 353-359. Date of Electronic Publication: 2022 Dec 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Anti-CD19 CAR-T therapy for EBV-negative posttransplantation lymphoproliferative disease-a single center case series.

  • Authors : Luttwak E; BMT Unit, Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel. .; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. .

Subjects: Immunotherapy, Adoptive* ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/drug therapy ; Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/Lymphoproliferative Disorders*/etiology

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2021 May; Vol. 56 (5), pp. 1031-1037. Date of Electronic Publication: 2020 Nov 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Report

Characteristics of Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein-Barr virus disease: favorable responses to rituximab.

  • Authors : Wei N; Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.; Wang Y

Subjects: Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/Epstein-Barr Virus Infections*/drug therapy ; Hematopoietic Stem Cell Transplantation* ; Lymphoproliferative Disorders*

  • Source: Bone marrow transplantation [Bone Marrow Transplant] 2021 Jun; Vol. 56 (6), pp. 1449-1451. Date of Electronic Publication: 2021 Jan 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,381 results for ""LYMPHOPROLIFERATIVE disorders""